NVTA - Invitae Corp - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - NVTA (1501134)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
39 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-07-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$22.49-3,789170,318-2%-$85,231
2019-06-13
NVTAStueland KatherineChief Commercial OfficerS - Sale$19.36-3,789174,107-2%-$73,356
2019-05-28
NVTAScott Randal WExec COBS - Sale$17.60-30,0003,490,669-1%-$528,027
2019-05-20
NVTAStueland KatherineChief Commercial OfficerS - Sale$18.21-6,474177,896-4%-$117,892
2019-05-20
NVTABrida ThomasGCS - Sale$18.21-2,146109,533-2%-$39,079
2019-05-20
NVTABendekgey E LeeCOOS - Sale$18.21-6,851161,588-4%-$124,757
2019-05-20
NVTAGeorge Sean EPres, CEOS - Sale$18.21-24,282480,007-5%-$442,175
2019-05-20
NVTAGuyer Shelly DCFOS - Sale$18.03-9,513147,352-6%-$171,539
2019-05-20
NVTANussbaum Robert LChief Medical OfficerS - Sale$18.21-7,202166,567-4%-$131,148
2019-05-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$18.36-1,000184,370-1%-$18,360
2019-05-14
NVTABendekgey E LeeCOOS - Sale$18.78-4,657168,439-3%-$87,439
2019-04-16
NVTAStueland KatherineChief Commercial OfficerS - Sale$25.23-1,000185,370-1%-$25,230
2019-03-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$23.49-1,000186,370-1%-$23,490
2019-02-27
NVTAGuyer Shelly DCFOS - Sale$20.00-4,000156,865-2%-$80,018
2019-02-27
NVTAStueland KatherineChief Commercial OfficerS - Sale$19.61-1,000187,370-1%-$19,610
2019-02-27
NVTADumond PattySee RemarksS - Sale$19.71-5,00088,811-5%-$98,540
2019-02-26
NVTABendekgey E LeeCOOS - Sale$19.62-4,650173,096-3%-$91,213
2019-02-25
NVTAScott Randal WExec COBS - Sale$19.10-30,0003,520,669-1%-$572,997
2019-01-16
NVTADumond PattySee RemarksS - Sale$15.00-3,00093,811-3%-$45,000
2019-01-16
NVTAGuyer Shelly DCFOS - Sale$14.49-4,000160,865-2%-$57,968
2019-01-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$13.59-1,000188,370-1%-$13,590
2019-01-10
NVTANussbaum Robert LChief Medical OfficerS - Sale$14.01-5,222163,769-3%-$73,153
A
2018-11-12
NVTANussbaum Robert LChief Medical OfficerS - Sale$13.11-10,444168,991-6%-$136,964
2018-12-17
NVTAStueland KatherineChief Commercial OfficerS - Sale$11.44-1,000189,370-1%-$11,437
2018-11-27
NVTAAguiar EricDirS - Sale$13.50-10,0000-100%-$135,000
2018-11-16
NVTADumond PattySee RemarksS - Sale$12.90-2,00096,811-2%-$25,800
M
2018-09-18
NVTADumond PattySee RemarksS - Sale$16.58-64598,811-1%-$10,695
2018-09-09
NVTAStueland KatherineChief Commercial OfficerS - Sale$13.62-595191,9630%-$8,104
2018-05-15
NVTAGuyer Shelly DCFOS - Sale$6.96-5,13539,865-11%-$35,740
2018-05-15
NVTAGeorge Sean EPres, CEOS - Sale$6.96-20,311409,289-5%-$141,365
2018-05-15
NVTANussbaum Robert LChief Medical OfficerS - Sale$6.96-6,70254,435-11%-$46,646
2018-05-15
NVTABendekgey E LeeCOOS - Sale$6.96-6,38852,396-11%-$44,460
2018-05-15
NVTABrida ThomasGCS - Sale$6.96-1,97925,973-7%-$13,774
2018-05-15
NVTAStueland KatherineChief Commercial OfficerS - Sale$6.96-6,01252,558-10%-$41,844
2018-05-15
NVTADumond PattySee RemarksS - Sale$6.96-5,01454,456-8%-$34,897
2018-04-02
NVTAScott Randal WExec COBP - Purchase$4.50+44,4443,550,669+1%+$199,998
2018-03-28
NVTABaker Bros. Advisors LP10%P - Purchase$4.50+1,111,1117,553,553+17%+$5,000,000
M
2017-10-09
NVTADumond PattyVP Fin., Principal Acct. OfficS - Sale$10.00-2,49752,168-5%-$24,970
2017-09-12
NVTAStueland KatherineChief Commercial OfficerS - Sale$9.40-61258,570-1%-$5,753
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top